TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reward (learning)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reward (effort-based)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reward (primary)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Etiological diagnosis of neurodegenerative disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of cachexia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of early reversal of adefunctioning ileostomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence of any POPCs within 30 days of surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Prescription rates of cardioprotective medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic accuracy of imaging techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of major adverse cardiac and cerebral events (MACCE)
Endpoint domain: Adverse events/effects
Primary endpoint: Intramyocardial haemorrhage (IMH)
Endpoint domain: Adverse events/effects
Primary endpoint: tp CR as assessed by local pathologist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety: Reliability
Endpoint domain: Adverse events/effects
Primary endpoint: Safety: Effectiveness
Endpoint domain: Adverse events/effects
Primary endpoint: early treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time and rate of union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Consultation of Urinary questionnaire Incontinence Short Form (ICIQ-UI-SF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manometric assessment of muscle strength and PFM endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial length of eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive percent agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative percent agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Distribution of immunoglobulin isotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: completeness of capturing standard stations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Energy Expenditure (Oxygen Consumption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Strides With Tibia Peak Positive Accelerations Above 3g
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Experience with healthcare received
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Experience with return to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Users' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge, Attitude and Behavior Scale on Evidence-Based Nursing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nursing Students' Awareness and Attitude Scale to Research and Developments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of confirmed HZ cases
Endpoint domain: Adverse events/effects
Primary endpoint: Upper limb function/activity performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Molecular identity profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclavicular recurrence free survival
Endpoint domain: Mortality/survival
Primary endpoint: Arginine-stimulated copeptine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Muscle Hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulvinar nucleus (PuN) activation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of 10-Hz visual Steady-State Response (ssVEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: usage behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of Anastomotic leak
Endpoint domain: Adverse events/effects
Primary endpoint: Neonatal Pain and Stress Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cystoscopy rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visual Analog Scale (VAS) of OLP lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Disease Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight status (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skeletally transverse measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dentolinear measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dentoangular measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of exclusive breastfeeding (EBF) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IPS Employment impact measure
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Assessment of psychiatric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of mental and physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Experiences of lymphedema symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lower Extremity Circumference Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life as measured by EORTC QLQ-C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of eyes improving 3 lines or more near visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain Threshold Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation of a tractography algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth of pathogens in blood culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants with TEAEs leading to study drug discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Behavioural change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: User comprehension
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of life of people with epilepsy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physical Literacy Vital Sign (PAVSped) total score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Unipedal Stance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agility T Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QVA questionnaire score difference
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Patient-reported pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in T2 (transverse relaxation time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enamel volume loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target lesion failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in number of parents who remain in the support group
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of support groups each parent attends
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: skin microbiome changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Quality of recorded signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Critical weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: American Orthopaedic Foot and Ankle Scale for first metatarsophalangeal joint
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The 36-Item Short Form Survey (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: quantification of the biofilm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Perception of General Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Perception of Body Image
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Perception of Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the curve (AUC) for thoracic fluid content (TFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) for lung ultrasound score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propofol dose in milligrams
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of functional independence at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average forced expiratory volume in 1 second (FEV1) AUC0-12h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate and severity of related treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of cell-mediated immune reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Conversion of positive crossmatch test to negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants With Treatment-Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Response Rate of DS-9606a
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Implant stability quotient (ISQ values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of imaging techniques to identify sentinel lymph nodes (SLN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving disease control status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of sessions performed out of the 8 sessions scheduled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of scheduled visits attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of withdrawals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visual acuity value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patients' pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of serious adverse events (SAEs) related to viral challenge
Endpoint domain: Adverse events/effects
Primary endpoint: Laboratory confirmed infection in ≥50% of participants
Endpoint domain: Physiological/clinical
Primary endpoint: Sexual dysfunction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incontinence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mindfulness Awareness Attention Scale (MAAS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Success in the performance of an MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of self-measurement of PVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and grades of treatment-emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of treatment discontinuation due to treatment-emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Therapeutic Benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HALP Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-kindness, self-judgement and mindfulness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidents of Adverse Events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: DEQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: OWS scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health Related Quality of Life (HR-QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Temporal lobe volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Whole brain white matter hyperintensities volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Whole brain cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients requiring NIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 1-year Recurrence-free survival (RFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Concordance between buccal cavity swab and nasal swab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Time Spent Out of Lane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Collisions
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the plasma concentration-time curve from time zero to time of last quantifiable concentration (AUC(0-T))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity/upright time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Admissions to inpatient care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Admissions to involuntary care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Days in involuntary care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sciatic nerve cross sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Success rate of upper trunk block and interscalene block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Syndesmotic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of neutrophil engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cumulative incidence of platelet engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cumulative incidence of transplant-related mortality (TRM)
Endpoint domain: Mortality/survival
Primary endpoint: Urinary inflammatory biomarkers associated with nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HCV incidence
Endpoint domain: Mortality/survival
Primary endpoint: serum level of Mannose Binding Lectin (MBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in serum phosphorous levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Success rate of the primary molar pulpotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Waist hip ratio (WHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous use of ProbeFix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls Efficacy Scale International (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of patients achieving target temperature < 34 ºC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final infarct volume (FIV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Plasma Area Under the Curve (AUC(0 to 36 Hour)) for Acyclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Acyclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pro-inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Impaired cerebral autoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Glaucoma neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Occupational sitting time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Leisure sitting time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total sitting time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success of Left Ventricular lead placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Serum-ferritin change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: N170 Latency to Upright Human Faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oculomotor Index of Gaze to Human Faces (OMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VABS: Vineland Adaptive Behavior Scales- III Socialization
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Catherine Bergego Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of anosognosia for neglect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core (rectal) temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergence of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Relief on VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extraction socket healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of non-hematological side effects grade ≥3
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subclavian catheter insertions with >1 skin puncture
Endpoint domain: Adverse events/effects
Primary endpoint: Visual analogue score (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Institutional delivery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Composition of a healthy infant microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative high-sensitive troponin T (hsTnT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Instructions memorized by parents
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: proportion of patients with any SSI
Endpoint domain: Adverse events/effects
Primary endpoint: bioimpedance-determined dry weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Presence or absence of SARSCoV-2 immunoglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of grade 3 and 4 treatment-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: change from baseline in parenting skills
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: change from baseline in parenting efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change from baseline in parent executive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: adherence to cardiac rehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: International Physical Activity Questionnaire (Short)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoring the Fagerstrom Test for Nicotine Dependence (FTND)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Beck's Depression Inventory (BDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Bohr's dead-space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AUC0-24h of Fexuprazan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes